CELL & GENE THERAPY INSIGHTS

  • Developing stem cell therapies: expansion strategies and lessons learned

    S Mei,
    L McIntyre,
    C Siler
    Shirley Mei, PhD, MSc
    Shirley Mei, PhD, MSc
    Investigator, OHRI
    Lauralyn McIntyre, MD, MHSc, FRCPC
    Lauralyn McIntyre, MD, MHSc, FRCPC
    Senior Scientist, OHRI
    Catherine Siler, PhD
    Catherine Siler, PhD
    Field Applications Scientist, Corning Life Sciences
    8 Dec 2021
    7
    Days
    14
    Hrs
    50
    Min
    Register
  • Putting the patient first: New modalities of manufacturing for cell...

    C White,
    B Wang,
    K Wang
    Chelsea C. White III
    Chelsea C. White III
    Schneider National Chair of Transportation & Logistics, H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology
    Professor Ben Wang
    Professor Ben Wang
    Gwaltney Chair in Manufacturing Systems, Executive Director, Georgia Institute of Technology
    Dr. Kan Wang
    Dr. Kan Wang
    Senior Research Engineer, Georgia Tech Manufacturing Institute, Georgia Institute of Technology
    9 Dec 2021
    8
    Days
    14
    Hrs
    50
    Min
    Register
  • Current technological trends and advancements in vector purification

    C Gaskin,
    A Saksule,
    N Clement et al.
    Chantelle Gaskin
    Chantelle Gaskin
    Field Applications Scientist, Thermo Fisher Scientific
    Ashish Saksule
    Ashish Saksule
    Cell and Gene Therapy Process Development Lead, Takeda
    Nathalie Clement, PhD
    Nathalie Clement, PhD
    Ying Cai, PhD
    Ying Cai, PhD
    Senior Director, Process Development, Ultragenyx Pharmaceutical
    Matthew Roach
    Matthew Roach
    AAV Process Development Team Leader, Precision BioSciences
    15 Dec 2021
    14
    Days
    14
    Hrs
    50
    Min
    Register
  • Advancing engineered cell and gene therapy with precision gene editing

    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now
  • Enabling clinical grade manufacturing of gene-engineered NK cells

    N Moker,
    E Ullrich,
    R Romee et al.
    Nina Möker
    Nina Möker
    R&D Reagents Manager, Allogeneic Cell Therapy, Miltenyi Biotec
    Prof. Dr. Evelyn Ullrich
    Prof. Dr. Evelyn Ullrich
    Arbeitsgruppe Zelluläre Immunologie, Universitätsklinikum, Frankfurt am Main (kgu.de)
    Rizwan Romee, MD
    Rizwan Romee, MD
    Associate Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute
    Volker Huppert
    Volker Huppert
    Chief Development Officer Glycostem Therapeutics
    30 November 2021
    Watch now
  • Magnetic selection for consistent cellular starting material in autologous...

    K Olsen,
    R Perret,
    Kenneth Olsen, PhD
    Kenneth Olsen, PhD
    Senior R&D Scientist, Personalized Medicine Business Unit, Lonza
     Rachel Perret, PhD
    Rachel Perret, PhD
    Team Leader, CAR T-cell Research Program, Malaghan Institute of Medical Research
    23 November 2021
    Watch now
  • Automated cell expansion: Current technologies and trends

    A Kilgore,
    D Sethi,
    K Schneider
    Gus Kilgore, PhD
    Gus Kilgore, PhD
    Global Marketing Manager, Terumo BCT
    Dalip Sethi, PhD
    Dalip Sethi, PhD
    Director, Scientific Affairs, Terumo BCT
    Kathie Schneider
    Kathie Schneider
    Director, Global Commercial Lead, Terumo BCT
    9 November 2021
    Watch now
  • Considerations for developing scalable and efficient collection network processes

    L Anderson,
    S Butler,
    A Montalvo
    Lacey Anderson
    Lacey Anderson
    Senior Manager, Collection Network Management, Be The Match BioTherapies
    Sara Butler
    Sara Butler
    Network Liaison, Be The Match BioTherapies
    Allison Montalvo,
    Allison Montalvo,
    Program Manager, Oncology, Janssen ( A division of J&J)
    28 October 2021
    Watch now
  • Platform optimization for efficient AAV purification – insights from a CDMO

    N Laroudie,
    V Ravault,
    Nicolas Laroudie
    Nicolas Laroudie
    Staff Scientist, Field Applications, Thermo Fisher Scientific
    Vincent Ravault
    Vincent Ravault
    DSP Expert, Process Development and Industrialization Department, YposKesi
    26 October 2021
    Watch now
  • Channel content

    Reports

    Latest content

    Navigating regulations - novel cell therapy platforms and their path to clinical...

    N Bauer,
    N Calhoun,
    A Davies et al.
    Nina Bauer
    Nina Bauer
    Head of Commercial, Gene Editing and Novel Modalities, Merck KGaA
    Natika Calhoun
    Natika Calhoun
    Regulatory Consultant, Merck KGaA
    Anthony Davies
    Anthony Davies
    Founder and CEO, Dark Horse Consulting
    Matt Muldoon
    Matt Muldoon
    Senior Director, Supplier Management, Allogene Therapeutics
    27 May 2021
    Watch now

    Addressing the challenges of purification & quality control in gene therapy

    A Bhattacharya,
    L Kopp,
    K Richter et al.
    Dr. Akash Bhattacharya
    Dr. Akash Bhattacharya
    Senior Application Engineer, Beckman Coulter
    Leisha Kopp
    Leisha Kopp
    Applications Scientist, Mirus Bio
    Klaus Richter, PhD
    Klaus Richter, PhD
    Group Leader AUC, Coriolis Pharma
    Dr. Audrey Chang
    Dr. Audrey Chang
    Vice President of Quality Control and Analytical Service, Vigene Biosciences
    Shawn Sternisha
    Shawn Sternisha
    Senior Field Applications Scientist, Beckman Coulter Life Sciences
    24 June 2021
    Watch now

    Are you finishing strong in cell therapy manufacturing? Tackling your final...

    D Sethi,
    A Cunningham,
    Dalip Sethi
    Dalip Sethi
    Manager, Senior Scientist at Terumo BCT
    Annie Cunningham
    Annie Cunningham
    Cell Therapy Laboratory Scientist
    31 August 2021
    Watch now

    Advancing engineered cell and gene therapy with precision gene editing

    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now

    Developing stem cell therapies: expansion strategies and lessons learned

    S Mei,
    L McIntyre,
    C Siler
    Shirley Mei, PhD, MSc
    Shirley Mei, PhD, MSc
    Investigator, OHRI
    Lauralyn McIntyre, MD, MHSc, FRCPC
    Lauralyn McIntyre, MD, MHSc, FRCPC
    Senior Scientist, OHRI
    Catherine Siler, PhD
    Catherine Siler, PhD
    Field Applications Scientist, Corning Life Sciences
    8 Dec 2021
    7
    Days
    14
    Hrs
    50
    Min
    Register

    Putting the patient first: New modalities of manufacturing for cell...

    C White,
    B Wang,
    K Wang
    Chelsea C. White III
    Chelsea C. White III
    Schneider National Chair of Transportation & Logistics, H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology
    Professor Ben Wang
    Professor Ben Wang
    Gwaltney Chair in Manufacturing Systems, Executive Director, Georgia Institute of Technology
    Dr. Kan Wang
    Dr. Kan Wang
    Senior Research Engineer, Georgia Tech Manufacturing Institute, Georgia Institute of Technology
    9 Dec 2021
    8
    Days
    14
    Hrs
    50
    Min
    Register